1. Home
  2. SPSC vs PHVS Comparison

SPSC vs PHVS Comparison

Compare SPSC & PHVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPS Commerce Inc.

SPSC

SPS Commerce Inc.

HOLD

Current Price

$54.99

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Pharvaris N.V.

PHVS

Pharvaris N.V.

HOLD

Current Price

$31.60

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPSC
PHVS
Founded
1987
2015
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
SPSC
PHVS
Price
$54.99
$31.60
Analyst Decision
Hold
Buy
Analyst Count
10
11
Target Price
$96.80
$41.82
AVG Volume (30 Days)
541.4K
329.9K
Earning Date
04-30-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
20.59
N/A
EPS
0.53
N/A
Revenue
$220,566,000.00
N/A
Revenue This Year
$8.85
N/A
Revenue Next Year
$7.37
N/A
P/E Ratio
$103.83
N/A
Revenue Growth
14.11
N/A
52 Week Low
$49.04
$16.00
52 Week High
$143.55
$33.33

Technical Indicators

Market Signals
Indicator
SPSC
PHVS
Relative Strength Index (RSI) 49.69 58.44
Support Level $52.67 $24.55
Resistance Level $59.85 $33.33
Average True Range (ATR) 2.22 1.33
MACD 0.21 0.15
Stochastic Oscillator 47.65 82.35

Price Performance

Historical Comparison
SPSC
PHVS

About SPSC SPS Commerce Inc.

SPS Commerce Inc is a provider of cloud-based supply chain management services for retailers, grocers, distributors, suppliers, and logistics firms to increase supply chain performance, optimize inventory levels and sell-through, reduce operational costs, improve order visibility, and satisfy consumer demands for a seamless omnichannel experience. Its solutions are delivered through the SPS Commerce platform and provide integrations and retail performance analytics to its customers. The company has one operating segment Supply Chain Management Solutions, that derives revenues from customers by providing access to cloud-based supply chain management services, primarily under subscription-based service arrangements.

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

Share on Social Networks: